Cornerstone Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-26,000
Closed -$3.33M 202
2022
Q1
$3.33M Sell
26,000
-780
-3% -$94K 0.2% 117
2021
Q4
$3.3M Hold
26,780
0.18% 128
2021
Q3
$3.81M Hold
26,780
0.22% 117
2021
Q2
$4.18M Buy
26,780
+14,420
+117% +$2.34M 0.25% 111
2021
Q1
$1.92M Hold
12,360
0.17% 134
2020
Q4
$1.85M Buy
+12,360
New +$1.75M 0.16% 126
2020
Q3
Sell
-9,270
Closed -$1.07M 219
2020
Q2
$1.07M Hold
9,270
0.1% 160
2020
Q1
$910K Hold
9,270
0.1% 140
2019
Q4
$1.35M Buy
+9,270
New +$1.28M 0.11% 157
2018
Q3
Sell
-3,090
Closed -$334K 237
2018
Q2
$334K Hold
3,090
0.04% 181
2018
Q1
$327K Hold
3,090
0.04% 196
2017
Q4
$362K Hold
3,090
0.04% 219
2017
Q3
$351K Hold
3,090
0.04% 233
2017
Q2
$385K Buy
+3,090
New +$366K 0.07% 206

Other funds holding ZBH

Cornerstone Advisors's ZBH Position: Q2 2022 in Review

Cornerstone Advisors sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 26,000 shares — an estimated $3.33M sold.

Cornerstone Advisors first reported a position in ZBH in Q2 2017 and held it in 14 quarters. The position peaked at $4.18M in Q2 2021. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Cornerstone Advisors reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
  • Cornerstone Advisors sold 26,000 Zimmer Biomet shares in Q2 2022, an estimated $3.33M.
  • Cornerstone Advisors first reported a position in Zimmer Biomet in Q2 2017 and held it in 14 quarters.
  • Cornerstone Advisors's Zimmer Biomet position peaked at $4.18M in Q2 2021.
  • 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Cornerstone Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.